141 related articles for article (PubMed ID: 38241777)
1. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
Guo Q; Liu N; Wang F; Guo Y; Yang B; Cao Z; Wang Y; Wang Y; Zhang W; Huang Q; Zhao W; Liu C; Qu T; Li L; Cao L; Ren D; Meng B; Qi L; Wang C; Cao W
Virchows Arch; 2021 Mar; 478(3):449-458. PubMed ID: 32918598
[TBL] [Abstract][Full Text] [Related]
3. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?
Trpkov K; Williamson SR; Gao Y; Martinek P; Cheng L; Sangoi AR; Yilmaz A; Wang C; San Miguel Fraile P; Perez Montiel DM; Bulimbasić S; Rogala J; Hes O
Histopathology; 2019 Aug; 75(2):174-184. PubMed ID: 30895640
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
[No Abstract] [Full Text] [Related]
5. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
[TBL] [Abstract][Full Text] [Related]
6. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
7. Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.
Zhang HZ; Xia QY; Wang SY; Shi MJ; Wang SY
Virchows Arch; 2022 May; 480(5):999-1008. PubMed ID: 35099634
[TBL] [Abstract][Full Text] [Related]
8. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study.
Skenderi F; Ulamec M; Vranic S; Bilalovic N; Peckova K; Rotterova P; Kokoskova B; Trpkov K; Vesela P; Hora M; Kalusova K; Sperga M; Perez Montiel D; Alvarado Cabrero I; Bulimbasic S; Branzovsky J; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):112-9. PubMed ID: 26180933
[TBL] [Abstract][Full Text] [Related]
9. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
[TBL] [Abstract][Full Text] [Related]
10. Low-Grade Oncocytic Tumor: Report of Two Cases of An Emerging Entity in the Spectrum of Oncocytic Renal Neoplasms.
Sharma D; Pai T; Prakash G; Desai S; Menon S
Turk Patoloji Derg; 2022; 38(2):162-166. PubMed ID: 34514579
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
[No Abstract] [Full Text] [Related]
12. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
13. [CK7+/CD117- low grade oncocytic tumor of the kidney: a clinicopathological analysis].
Bai YF; Chang CD; Wang B; Zhao M; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):976-980. PubMed ID: 36207909
[No Abstract] [Full Text] [Related]
14. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
15. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O
Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607
[TBL] [Abstract][Full Text] [Related]
16. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
17. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
18. Low-grade oncocytic tumor (LOT) - a new renal entity ready for a prime time: An updated review.
Mansoor M; Siadat F; Trpkov K
Histol Histopathol; 2022 May; 37(5):405-413. PubMed ID: 35156688
[TBL] [Abstract][Full Text] [Related]
19. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
Morini A; Drossart T; Timsit MO; Sibony M; Vasiliu V; Gimenez-Roqueplo AP; Favier J; Badoual C; Mejean A; Burnichon N; Verkarre V
Mod Pathol; 2022 Mar; 35(3):352-360. PubMed ID: 34531523
[TBL] [Abstract][Full Text] [Related]
20. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.
Kapur P; Gao M; Zhong H; Chintalapati S; Mitui M; Barnes SD; Zhou Q; Miyata J; Carrillo D; Malladi VS; Rakheja D; Pedrosa I; Xu L; Kinch L; Brugarolas J
Mod Pathol; 2022 Mar; 35(3):333-343. PubMed ID: 34538873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
